Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.

Area of Science:

• Pulmonology
• Oncology
• Preventive Medicine

Background:

• Lung cancer is a leading cause of cancer death in the US, with smoking as the primary risk factor.
• Early-stage lung cancer has a better prognosis and is more treatable than advanced disease.
• The US Preventive Services Task Force (USPSTF) previously updated its recommendations in 2013.

Purpose of the Study:

• To update the 2013 USPSTF recommendation on lung cancer screening.
• To evaluate the accuracy, benefits, and harms of low-dose computed tomography (LDCT) screening.
• To determine optimal screening ages, intervals, and strategies using modeling studies.

Main Methods:

• A systematic review was conducted on LDCT screening accuracy, benefits, and harms.
• A collaborative modeling study informed decisions on screening parameters.
• The study population included adults aged 50-80 with a 20 pack-year smoking history (current or former smokers within 15 years).

Main Results:

• Annual LDCT screening demonstrates a moderate net benefit for high-risk individuals.
• Risk assessment considers age, smoking history (pack-years), and time since quitting.
• The USPSTF concluded with moderate certainty regarding the benefits of screening.

Conclusions:

• The USPSTF recommends annual lung cancer screening with LDCT for adults aged 50-80 with a 20 pack-year smoking history.
• Screening should cease if a person has quit smoking for 15 years or has a condition limiting life expectancy or surgical options.
• This updated recommendation lowers the starting age and pack-year threshold compared to the 2013 guidelines.